Rates of Dissatisfaction High for Hidradenitis Suppurativa Care
MONDAY, April 7, 2025-- The rates of respondent dissatisfaction with current hidradenitis suppurativa (HS) treatment options are high, likely due to undertreatment with available therapies, according to study published in the April issue of the...
Read more »
Pharmaceutical news
Study Sheds Light on Role of Risk Factors in Young-Onset Cryptogenic Ischemic Stroke
CT Exams in 2023 Projected to Result in 103,000 Future Cancers
Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
Poor Communication Major Contributor to Patient Safety Incidents
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Twins Have Less Fat Accumulation Than Singletons Beginning in Early Pregnancy
Early Pregnancy BP Trajectories Linked to New-Onset HTN Years Later
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
Yoga May Aid Knee Osteoarthritis Pain
Fewer Americans Traveled for Abortions in 2024, Report Finds
New Endangered Species Rule Would No Longer Count Habitat Loss as 'Harm'
Medical Mistrust Could Be Harming Hep A Vaccination Rates Among Gay, Bisexual Men
Smoking/Vaping Combo Poses Health Risks
Alternative To Hip Replacement Helps Patients Remain Physically Active
